The UK's move follows a recent decision by the TGA's Advisory Committee on Medicines Scheduling to reject an over the counter move for erectile dysfunction medicines for a second time.

Latest Video
New Stories
-
EBOS reports earnings growth as it prepares for Chemist Warehouse
February 21, 2019 - - Latest News -
MA: Where are the service standards and KPIs?
February 21, 2019 - - Latest News -
MA appoints two new board members
February 21, 2019 - - Latest News -
A nine month post-PBAC process?
February 21, 2019 - - Latest News -
What next for payment reform?
February 20, 2019 - - Latest News -
New report calls for greater focus on secondary CV events
February 20, 2019 - - Latest News -
Fee 'crunch' for smaller companies and patient populations
February 20, 2019 - - Latest News